Fertility Family, a leading provider of fertility supplements in the UK, has announced its participation in the upcoming Women’s Health Professional Care conference, taking place on Monday 26 and Tuesday 27 February at Olympia London. The event, dedicated to improving health outcomes for women, will bring together healthcare professionals and policymakers from primary and secondary care to address gender disparities and provide fresh insights into a range of health issues affecting women.
A key part of the conference is the symposium hosted by Fertility Family, titled “PCOS: Optimising Metabolic and Reproductive Health in Women from Adolescence to Menopause”. The session, led by Dr Priya Bhide and Dr Srividya Seshadri, will explore the lifelong implications of Polycystic Ovary Syndrome (PCOS) and equip general practitioners with essential strategies for managing the condition across different life stages.
PCOS is a complex condition that affects women’s metabolic, reproductive, and psychological health. The symposium will provide evidence-based strategies to support early diagnosis, improve fertility and pregnancy outcomes, and address cardiometabolic concerns during perimenopause. Scheduled for 10:45 am to 11:15 am in the Contraceptive and Reproductive Health Theatre, the session aims to offer practical insights for holistic, age-appropriate care.
Dr Priya Bhide is a clinical reader at Queen Mary University of London and a senior clinician at the Homerton Fertility Centre. She has extensive experience in reproductive medicine and assisted conception, with a research focus on reproductive endocrinology, PCOS, subfertility, and assisted conception. She also leads the Obstetrics and Gynaecology module for undergraduate teaching at Barts and the London School of Medicine and Dentistry.
Dr Srividya Seshadri is a consultant gynaecologist and an accredited subspecialist in reproductive medicine and surgery. She serves as an Honorary Associate Professor at University College London and is a member of the Executive Committee of the British Fertility Society. She completed her MD thesis on reproductive immunology at the University of Liverpool and holds accreditations in reproductive medicine and surgery from Guy’s and St Thomas’ NHS University Hospital in London.
Terry Sullivan, managing director at Fertility Family, emphasised the significance of the event: “We are pleased to be involved in this important educational event. It is a privilege to help facilitate delivery of key information to GPs and other healthcare professionals that can make a dramatic difference to the lives of women from adolescence to post-menopause.”
Dr Seshadri highlighted the importance of early intervention: “Patient education, early diagnosis, and detection of PCOS enable optimisation of this metabolic condition and are crucial for improving the overall health and well-being of women.”
Dr Bhide added: “Polycystic Ovary Syndrome (PCOS) is one of the most common yet underdiagnosed conditions affecting women, with implications that extend far beyond reproductive health. From increased risks of diabetes and cardiovascular disease to the emotional toll of infertility, PCOS impacts several aspects of a woman’s well-being. This symposium highlights the critical role GPs play in early diagnosis and tailored management, ensuring women receive the comprehensive care they need at every stage of life.”
With PCOS affecting one in ten women in the UK, the session at Women’s Health Professional Care 2025 will serve as a vital platform for healthcare professionals to enhance their understanding of the condition and adopt more effective treatment approaches.
